HEPATIC GENE-THERAPY - EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO RAT HEPATOCYTES IN-VIVO

Citation
Tm. Kolodka et al., HEPATIC GENE-THERAPY - EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO RAT HEPATOCYTES IN-VIVO, Somatic cell and molecular genetics, 19(5), 1993, pp. 491-497
Citations number
16
Categorie Soggetti
Cytology & Histology","Genetics & Heredity",Biology
ISSN journal
07407750
Volume
19
Issue
5
Year of publication
1993
Pages
491 - 497
Database
ISI
SICI code
0740-7750(1993)19:5<491:HG-ERG>2.0.ZU;2-H
Abstract
The rat is an excellent model for gene therapy because there are many rat models for human diseases. We have developed a simple and efficien t method to deliver genes to the rat liver using recombinant retrovira l vectors. A 70% partial hepatectomy followed by retroviral infusion i nto the por tal vein results in 10-15% hepatocyte transduction in vivo . This is 10 times more efficient than in the mouse due partially to t he observation that the rat livers have much more synchronous hepatocy te replication after partial hepatectomy. Using a recombinant retrovir al vector containing the human alpha(1)-antitrypsin cDNA, persistent e xpression of the human protein in recipient rat plasma was observed fo r at least six months and at a level that is 10 times greater than the mouse. Thus, rats can serve as an excellent model for gene therapy of metabolic disorders secondary to hepatic deficiencies.